Onconetix Correlations
ONCO Stock | USD 0.80 0.29 26.61% |
The current 90-days correlation between Onconetix and Verde Clean Fuels is 0.08 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Onconetix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Onconetix moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Onconetix Correlation With Market
Average diversification
The correlation between Onconetix and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Onconetix and DJI in the same portfolio, assuming nothing else is changed.
Onconetix |
Moving together with Onconetix Stock
0.63 | A | Agilent Technologies | PairCorr |
0.7 | ME | 23Andme Holding | PairCorr |
0.74 | VALN | Valneva SE ADR | PairCorr |
0.8 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.78 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.82 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.76 | IPSC | Century Therapeutics | PairCorr |
0.67 | MTEM | Molecular Templates | PairCorr |
0.73 | NKTX | Nkarta Inc | PairCorr |
0.68 | TPST | Tempest Therapeutics | PairCorr |
0.81 | AGL | agilon health Buyout Trend | PairCorr |
0.78 | TCHH | Trustcash Holdings | PairCorr |
0.74 | SHG | Shinhan Financial | PairCorr |
0.68 | EC | Ecopetrol SA ADR | PairCorr |
0.63 | WF | Woori Financial Group | PairCorr |
0.75 | HYMTF | Hyundai Motor | PairCorr |
0.71 | TLK | Telkom Indonesia Tbk | PairCorr |
Moving against Onconetix Stock
0.72 | MDGL | Madrigal Pharmaceuticals | PairCorr |
0.61 | RNXT | RenovoRx | PairCorr |
0.38 | NXGLW | NexGel Warrant | PairCorr |
0.37 | KEP | Korea Electric Power | PairCorr |
0.77 | BAC | Bank of America Aggressive Push | PairCorr |
0.72 | T | ATT Inc Sell-off Trend | PairCorr |
0.71 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.69 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
0.65 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.6 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.47 | HPQ | HP Inc | PairCorr |
0.4 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.38 | VFS | VinFast Auto Earnings Call Today | PairCorr |
0.36 | HD | Home Depot | PairCorr |
Related Correlations Analysis
0.57 | 0.5 | 0.49 | -0.31 | VGAS | ||
0.57 | 0.56 | 0.61 | -0.08 | CCEC | ||
0.5 | 0.56 | 0.37 | -0.13 | TSEM | ||
0.49 | 0.61 | 0.37 | -0.2 | ARM | ||
-0.31 | -0.08 | -0.13 | -0.2 | CVWFF | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Onconetix Stock performing well and Onconetix Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Onconetix's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
VGAS | 2.73 | 0.14 | 0.04 | 0.26 | 3.15 | 7.07 | 25.46 | |||
CCEC | 1.49 | 0.15 | 0.03 | 0.69 | 1.81 | 4.13 | 13.94 | |||
TSEM | 1.85 | 0.08 | 0.05 | 0.17 | 2.62 | 3.85 | 16.72 | |||
ARM | 2.76 | (0.14) | 0.00 | 0.06 | 3.91 | 5.88 | 18.78 | |||
CVWFF | 0.96 | (0.08) | 0.00 | (0.50) | 0.00 | 1.64 | 28.54 |
Onconetix Corporate Management
MD MBA | Chief Officer | Profile | |
Christian Bruhlmann | Chief Officer | Profile | |
Dr Very | Senior Development | Profile | |
Theodore Yoho | Head Development | Profile | |
Erin Henderson | Consultant | Profile | |
Brian Price | Head Strategy | Profile | |
Ali Fattom | Head Discovery | Profile |